There's a slightly better picture of what comes next for Maryland's coronavirus vaccine distribution plan.

It's not an exact timeline by any means, but it's the closest thing, so far. There's word Wednesday that Marylanders could start getting the vaccine in about two weeks.

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

"There is good news on the horizon," Lt. Gov. Boyd Rutherford said. "We expect that we will be receiving vaccines in the very near future."

U.S. officials are expected to give approval for a coronavirus vaccine as early as next week. This after the UK approved Pfizer's coronavirus vaccine early Wednesday morning.

Maryland could get its first shipment of the coronavirus vaccine as early as mid-December, Rutherford said at Wednesday morning's Board of Public Works meeting with a word of caution.

"Everyone is not going to get a vaccine, or the ability to get a vaccine right away. We're only going to get a small amount, and so it's going to have to go to the health care workers," Rutherford said.

Federal officials are sending Maryland 155,000 doses in the first batch of vaccines, Gov. Larry Hogan told 11 News Tuesday evening, but he said that's simply not enough.

"That's a tiny fraction of what we need," Hogan said Tuesday. "It covers half of our frontline health care workers. It doesn't get anywhere near what we need in phase one."

As detailed in Maryland's vaccine distribution roadmap, advisers with the U.S. Centers for Disease Control and Prevention said health care professionals and nursing home residents should be at the front of the line for the first shots; however vaccine supply will be so limited at the outset that the CDC panel said subsets of health care professionals will have to be targeted.

Members of the panel also said they worry that since baseline mortality among long-term care residents is already high, "deaths temporarily associated with a vaccine in the early phases … could reduce public confidence in the safety of COVID-19 vaccines."